New methods to evaluate endothelial function: Non-invasive method of evaluating endothelial function in humans

Journal of Pharmacological Sciences

Volumn 93, Issue 4, 2003, Pages 405-408

  Hashimoto, Masayoshi ^a   Miyamoto, Yoshitomo ^a   Matsuda, Yasuaki ^a   Akita, Hozuka ^a  

^a KOBE UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Coronary risk factor; Endothelium; Estrogen; Vasodilation

Indexed keywords

CALCIUM; CONJUGATED ESTROGEN; ESTROGEN; GLYCERYL TRINITRATE; MEDROXYPROGESTERONE; NITRIC OXIDE; SEX HORMONE;

ARTERY DILATATION; BLOOD FLOW; BRACHIAL ARTERY; CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY RISK; DIABETES MELLITUS; DRUG DOSE REDUCTION; DRUG EFFECT; ECHOGRAPHY; EPIDEMIOLOGICAL DATA; ESTROGEN THERAPY; HORMONE SUBSTITUTION; HUMAN; HYPEREMIA; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; LONG TERM CARE; MENOPAUSAL SYNDROME; NON INVASIVE MEASUREMENT; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PREMENOPAUSE; REVIEW; SEX DIFFERENCE; SHORT COURSE THERAPY; SMOKING HABIT; VASCULAR ENDOTHELIUM;

BRACHIAL ARTERY; CLINICAL TRIALS; CORONARY ARTERIOSCLEROSIS; ENDOTHELIUM, VASCULAR; ESTROGEN REPLACEMENT THERAPY; FEMALE; FOREARM; HUMANS; MALE; NITROGLYCERIN; RISK FACTORS; VASODILATOR AGENTS;

EID: 1042292680     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.93.405     Document Type: Review

References (11)

1. Galatius S, Wroblewski H, Sorensen VB, Bie P, Parving HH, Kastrup J. Endothelin and von Willebrand factor as parameters of endothelial function in idiopathic dilated cardiomyopathy: Different stimuli for release before and after heart transplantation? Am Heart J. 1999;137:549-554.
2. Conway DS, Pearce LA, Chin BS, Hart RG, Lip GY. Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation. Circulation. 2003;107:3141-3145.
3. Perez-Jimenez F, Castro P, Lopez-Miranda J, et al. Circulating levels of endothelial function are modulated by dietary monounsaturated fat. Atherosclerosis. 1999;145:351-358.
4. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111-1115.
5. Corretti MC, Anderson TJ, Benjamin EJ, et al. International brachial artery reactivity task force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39:257-265.
6. Hashimoto M, Akishita M, Eto M, et al. Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle. Circulation. 1995; 92: 3431-3435.
7. Hashimoto M, Akita H. Cerivastatin, a hydroxymethylglutaryl coenzyme a reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days. Circulation. 2002;105:E30-E31.
8. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol. 1994;24:1468-1474.
9. Hashimoto M, Kozaki K, Eto M, et al. Association of coronary risk factors and endothelium-dependent flow-mediated dilatation of the brachial artery. Hypertens Res. 2000;23:233-238.
10. Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menoapause and risk of cardiovascular disease: The Framingham study. Ann Intern Med. 1976;85:447-452.
11. Hashimoto M, Miyao M, Akishita M, et al. Effects of long-term and reduce-dose hormone replacement therapy on endothelial function and intima-media thickness in postmenopausal women. Menopause. 2002;9:58-64.